20 June 2013
Keywords: Medicis, Anacor, Acne drug, Research, Development
Article | 11 February 2011
US companies Medicis Pharmaceutical (NYSE:MRX) and Anacor Pharmaceuticals (Nasdaq: ANAC) have entered into an R&D agreement to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 February 2011
19 June 2013
© 2013 thepharmaletter.com